Eli Lilly obesity drug delivers 20% weight loss, bolstering investment case for new therapies

A woman walks down the street on Michigan Avenue in Chicago, Illinois.
Jeff Haynes | AFP | Getty Images

Clinical trial data released Thursday by Eli Lilly reinforces the belief that a wave of obesity treatments are on the horizon that could be gamechangers for patients struggling to lose weight and perhaps investors as well.